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404-1 In Vivo Magnetic Resonance Evaluation of the Effects of 
Mouse Embryonic Stem Cells on Cardiac Function
Takayasu Arai, Jorg de Bruin, Theo Kofidis, Ross Venook, Michael V. McConnell, 
Thomas Quertermous, Robert Robbins, Phillip C. Yang, Stanford University, Stanford, CA
Introduction. Congestive heart failure continues to be a major public health problem
despite recent medical advances. Cell transplantation may offer therapeutic potential to
salvage the injured myocardium. In vivo assessment of the transplanted cells has been
described using non-invasive imaging methods. However, systematic longitudinal analy-
sis of the effects of transplanted cells has not been done.
Purpose. This study performs a longitudinal evaluation of cardiac function in infarct
mouse model following the transplantation of mouse embryonic stem cells (mESC).
Methods. The mESC were labeled using small paramagnetic iron oxide agents. LAD
ligation was done followed by injection of mESC into the infarct area. The mice were
divided into 4 groups: sham-operated, LAD-ligated, LAD-ligated with non-labeled mESC,
and LAD-ligated with labeled mESC. The images were acquired using ECG-triggered
cine sequence. LV ejection fraction (LVEF) and LV mass (LVM) were calculated blindly.
Results. Significant restoration of LVEF and LVM were observed in the mESC treated
group at each time point. The mESC treated group demonstrated mean LVEF of 37.9%
vs. untreated of 28.6%. A significant increase was also observed in mean LVM in the
treated group of 51.4 mg vs. untreated of 34.2 mg. Finally, reliable imaging of the labeled
mESC was observed during the 4-week duration.
Conclusions. In vivo MR imaging of the labeled mESC enable identification of the cells
and assessment of their therapeutic effects on the cardiac function. 
9:30 a.m.
404-2 Aspirin Resistance in Cardiovascular Disease: 
Underdosing of Overweight Patients
Andrew O. Maree, Ronan Curtin, Michelle Dooley, Peter Crean, Denis Shields, Dermot 
Cox, Desmond J. Fitzgerald, The Royal College of Surgeons in Ireland, Dublin 2, Ireland, 
Beaumont Hospital, Dublin 2, Ireland
Background: “Aspirin resistance” may result from failure to inhibit platelet cyclooxygen-
ase and thromboxane (Tx) generation, or platelet activation via aspirin-insensitive path-
ways. We examined the mechanisms involved in a population with stable cardiovascular
disease.
Methods: Patients (n=199) on aspirin 75–300mg daily were screened by Platelet Func-
tion Analyser (PFA) –100. Serum TxB2 levels and platelet aggregation to arachidonic
acid (AA 1.6mM) were performed in 142 patients. In 50 patients, additional analysis
included aggregation to epinephrine (5uM), collagen (0.5ug/ml) and TRAP (5uM) and
assay of platelet TxB2 generated in response to AA. Platelet surface expression of IIb/
IIIa, Ib, Ia/IIa and TRAP induced p-selectin were determined.
Results: 29 (15%) patients were aspirin resistant, failing to prolong the PFA-100 closure
times (over 193 seconds). PFA-100 closure times and serum TxB2 were inversely related
(r = -0.23; p = 0.002). Serum TxB2 in turn correlated strongly with platelet TxB2 gener-
ated in response to AA (r = 0.69; p = 0.0001) and with platelet aggregation to AA (R2 =
0.57; p = 0.0007), epinephrine (r = 0.3; p = 0.04), and TRAP (r = 0.4; p = 0.002) but not
collagen (r = 0.16; p = 0.24). Patients with a serum TxB2 above 4ng/mg (25% of popula-
tion) generated 14-fold greater levels of platelet TxB2 (291 +/- 35 vs 21 +/- 12 ng/mg; p =
0.0001). In every case platelet aggregation to AA was inhibited by addition of aspirin in
vitro. Patient weight correlated with serum TxB2 levels (r = 0.17; P = 0.05), particularly in
patients on 75mg enteric-coated aspirin (74% of population; r = 0.29; P = 0.002). Aspirin
resistance was also associated with higher platelet GPIIb/IIIa (p = 0.03), GPIb (p = 0.04)
and TRAP induced p-selectin (p = 0.02), unrelated to the continued generation of
Tx.Conclusion: In a stable cardiovascular population, 15% of patients were aspirin
resistant. Failure to inhibit platelet Tx was a major contributor, although Tx-independent
pathways were also involved. Continued Tx generation was related to weight particularly
in patients on a 75mg enteric-coated aspirin preparation. Such preparations may provide
an inadequate dose of aspirin in overweight patients.
9:45 a.m.
404-3 Dual Regulation of Endothelial Nitric Oxide Synthase by 
Rho-Kinase
Yoshiyuki Rikatake, Rosario Scalia, Michael A. Moskowitz, James K. Liao, Brigham & 
Women's Hospital, Cambridge, MA
Background: Rho-kinase plays an important role in cardiovascular disease. However, the
mechanism by which inhibition of Rho-kinase leads to cardiovascular protection is not
known. Methods and Results: Human vascular endothelial cells were treated with the
Rho-kinase inhibitor, hydroxyfasudil (HF), and Akt activity and eNOS expression/activity
were measured. In a concentration-dependent manner, HF stimulates eNOS activity
acutely via activating phosphatidylinositol 3-kinase (PI3-K)/Akt pathway and chronically
by increasing eNOS expression. Chronic treatment with fasudil inhibits leukocyte-endot-
helial interaction after ischemia/reperfusion injury and reduced cerebral infarct size and
neurological deficits following transient middle cerebral artery occlusion. These effects
correlated with decreased Rho-kinase activity and inversely with increased eNOS
expression. Indeed, the cardiovascular protective effects of fasudil were blocked by the
NOS inhibitor, L-NAME, and were absent in eNOS-deficient mice. In contrast, the rapid
or acute cardiovascular protective effect of fasudil in ischemia-reperfusion injury and
models of myocardial and cerebral infarction was not associated with changes in eNOS
expression but instead, was completely blocked by PI3-K and eNOS inhibitors. Conclu-
sion: These findings indicate that the anti-inflammatory and anti-ischemic effects of Rho-
kinase inhibition occur through 2 different mechanisms involving upregulation of eNOS
expression and activity. These results suggest that Rho-kinase may be an important ther-
apeutic target for cardiovascular protection.
10:00 a.m.
404-4 Dynamic Changes of Gene Expression in Hypoxia-
Induced Right Ventricular Hypertrophy
Saumya Sharma, Heinrich Taegtmeyer, Julia Adrogue, Peter Razeghi, Shiraj Sen, 
Kholiswa Ngumbela, M. Faadiel Essop, University of Texas Houston Medical School, 
Houston, TX, University of Capetown Faculty of Medical Sciences, Capetown, South 
Africa
Background: Hypobaric hypoxia induces right ventricular hypertrophy. The relative con-
tribution of pulmonary hypertension, decreased arterial oxygen, and neuroendocrine
stimulation to the transcriptional profile of hypoxia-induced right ventricular hypertrophy is
presently unknown. While both ventricles are exposed to hypoxia and neuroendocrine
stimulation, only the right ventricle is exposed to increased load.Methods: Right and left
ventricular tissue was evaluated microscopically to determine myocyte size and fibrosis.
We measured the expression of candidate genes by quantitative RT-PCR in the right ven-
tricle of rats exposed to hypobaric hypoxia (11% O2) and compared the results with the
left ventricle to determine the effect of load. Results: Hypobaric hypoxia induced right
ventricular hypertrophy without fibrosis. In the right but not the left ventricle, ANF tran-
script levels increased at 7 days and continued to rise at 14 days. Metabolic genes such
PPARalpha, PPARalpha-regulated genes, GLUT1 and GLUT4 were differentially regu-
lated in a manner suggesting a substrate switch from fatty acid to glucose oxidation early
during hypobaric hypoxia and a switch back to fatty acid oxidation at 14 days. There was
also a dramatic switch in myosin isogene expression early in the course of hypobaric
hypoxia, whereas later both myosin isoforms were upregulated. SERCA2a expression
was downregulated early in the right ventricle, while at 14 days transcript levels were
increased. When comparing right and left ventricular gene expression, the transcript lev-
els of all genes, except for myosin isoforms and PDK-4 differed dramatically, suggesting
that all these genes are regulated by load.Conclusion: Dynamic changes in gene
expression occur in hypoxia-induced right ventricular hypertrophy, characterized by an
early reactivation of the fetal transcriptional profile followed by a reversion to the “adult”
pattern by 14 days. Furthermore, myosin iso-gene and PDK-4 expression is not affected
by load suggesting that either hypoxia itself or neuroendocrine stimulation are the pri-
mary regulators of these genes
